Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2008
04/30/2008CN101167758A Method for preparing antiviral natural polymerization polysaccharide and oligosaccharide
04/30/2008CN101167748A Sterilization haemostatic powder
04/30/2008CN101167737A Application of cimetidine, ribavirin, chlorpheniramine maleate, vitamin B12 and amidopyrine in preparing medicine for treating herpes zoster
04/30/2008CN101167736A Azithromycin microball preparation and preparation method thereof
04/30/2008CN101167732A Method for preparing glycylcycline freezing-dried powder injection
04/30/2008CN101167719A Gallo catechin and gallate microcapsule granule and preparation technique thereof
04/30/2008CN101167715A Skin disinfectant
04/30/2008CN101167712A Chloromycetin eyedrops and preparation method thereof
04/30/2008CN101167708A New use of 6,7-dehydroroyleanone in pharmaceutical
04/30/2008CN101167704A Nosiheptide taste-masked microcapsule and preparation method thereof
04/30/2008CN101167703A Chloromycetin soft capsule and preparation method thereof
04/30/2008CN101167702A Roxoithromycin osmotic pump tablet and preparation method thereof
04/30/2008CN101167692A Chinese medicinal herb health-care foot bath composition
04/30/2008CN100385005C Methods for the production of multimeric proteins, and related compositions
04/30/2008CN100385002C Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins
04/30/2008CN100384998C Method for preparing recombinant goose interleukin-2 protein and its application
04/30/2008CN100384988C Chicken astrovirus type 2
04/30/2008CN100384985C Attenuated eel vibrio strain and its application
04/30/2008CN100384982C Antrodia camphorata mycelium fermented extract and application thereof
04/30/2008CN100384880C Modified peptides as therapeutic agents
04/30/2008CN100384879C Modified peptides as therapeutic agents
04/30/2008CN100384863C Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
04/30/2008CN100384857C Cephalosporin ester compound resisting beta-lactamase and its salt
04/30/2008CN100384845C Process for formulation of antibiotic compounds
04/30/2008CN100384830C Derivative of cyclo membranousol kind and application thereof
04/30/2008CN100384476C Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine
04/30/2008CN100384472C Antigen-specific lgE antibody production inhibitors
04/30/2008CN100384458C Liver beneficial pharmaceutical composition and method for preparing the same
04/30/2008CN100384440C Chinese medicinal composition for treating animal virus zymosis
04/30/2008CN100384438C Antiviral powder, antiviral extract, and pharmaceutical preparation containing said powder and/or said extract
04/30/2008CN100384431C Traditional Chinese medicine compositions
04/30/2008CN100384427C Injection preparation containing active component adefuwei or its salt and its preparation method
04/30/2008CN100384426C Solid dispersion containing active component adefuwei or its salt and its preparation method
04/30/2008CN100384423C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/30/2008CN100384422C Anti-microbial composition comprising a metal ion chelating agent
04/30/2008CN100384414C Medicine containing ketone effective component
04/29/2008US7365191 immunology; antitumor agents; viricides; anticancer agents; antiinflammatory agents; oligosaccharde containing glucose, galactose, mannose
04/29/2008US7365174 Azalide and azalactam derivatives and method for producing the same
04/29/2008US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis
04/29/2008US7365170 Reagents for regulation of metabolic events, such as those mediated by adiponectin and adiponectin agonists. The invention also provides screening assays for identification of biologically active agents, diagnostic and therapeutic agents
04/29/2008US7365169 T-bet antibodies
04/29/2008US7365155 Immunoregulator
04/29/2008US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
04/29/2008US7365071 Heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as β-lactamase inhibitors and antibacterials
04/29/2008US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate
04/29/2008US7365053 Staphylococcal infection; controlling the growth of a microorganism
04/29/2008US7364919 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides
04/29/2008US7364749 Preventing scar tissue formation on the trachea, bonchi or alveoli by administering liposomes containing povidone iodine along with an antiinflammatory agent, anesthetic, antioxidant, antibiotic, or corticoid
04/29/2008US7364744 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
04/29/2008US7364741 Peptides of human Papilloma virus for use in human T cell response inducing compositions
04/29/2008US7364739 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections
04/29/2008US7364738 Monoclonal antibodies to the CLFA protein and method of use in treating infections
04/29/2008US7364733 antibodies that bind to Activated CD4+ T-cells (ACT-4) receptors; diagnostic or therapeutic use for immune disorders; selective suppression of immune response; allograft rejection, graft versus host disease, autoimmune diseases, allergies
04/29/2008US7364729 Method of inducing a CTL response
04/29/2008US7364724 Recombinant super-compound interferon
04/29/2008CA2425494C Process for making 3-amino-2-chloro-4-methylpyridine
04/29/2008CA2370098C Human beta-trcp protein
04/29/2008CA2343204C Arylsulfonanilide ureas
04/29/2008CA2338776C Novel c-2 s/o- and s/n formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and .beta.-lactamase inhibitors
04/29/2008CA2305331C Methods for decreasing the frequency of transmission of viral and for preventing and treating bacterial infections using cellulose acetate phthalate or hyroxypropyl methylcellulose phthalate excipients
04/29/2008CA2273074C In ovo vaccination against newcastle disease
04/29/2008CA2268957C Immune response modifier compounds for treatment of th2 mediated and related diseases
04/29/2008CA2177952C Nucleosides and oligonucleotides containing boron clusters
04/27/2008CA2608478A1 Skin disinfectant
04/24/2008WO2008048538A1 Hiv integrase inhibitors
04/24/2008WO2008047909A1 Novel method for production of 1-methylcarbapenem and novel intermediate
04/24/2008WO2008047821A1 Fused heterocyclic compound
04/24/2008WO2008047681A1 Benzimidazole compound having gastric acid secretion inhibitory activity
04/24/2008WO2008047680A1 External preparation for skin
04/24/2008WO2008047658A1 Animal feed additive and animal feed
04/24/2008WO2008047391A1 Nutriceutic composition comprising lactoferrin and proteasic probiotics
04/24/2008WO2008046860A2 Bioavailable combinations for hcv treatment
04/24/2008WO2008046796A2 Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections
04/24/2008WO2008046314A1 The new use of honeysuckle leaf in treating aids
04/24/2008WO2008046251A1 Fusion proteins containing n domain of human calreticulin and human papillomavirus type 16 e6 or e7 and uses thereof
04/24/2008WO2008046202A1 USE OF PYπDOXAL-5'-PHOSPHATE FOR IMPROVING THE IMMUNE RESPONSE AND TREATMENT AND PREVENTION OF POST-OPERATIVE INFECTIONS
04/24/2008WO2008030512A3 Polystyrene sulfonate polymer tablets, their preparation and use
04/24/2008WO2008016300A3 Antibiotic composition
04/24/2008WO2008011116A3 Aza-peptide protease inhibitors
04/24/2008WO2008008537A3 Combi) compositions for the treatment of mucormycosis. comprising iron chelator and antifungal agent
04/24/2008WO2008006979B1 Process for preparing diaminophenothiazinium compounds
04/24/2008WO2008005519A3 Novel pyridazine compound and use thereof
04/24/2008WO2008001166A3 Process for synthesis of glycomimicking cationic amphiphiles
04/24/2008WO2008000881A9 Glycosylated human alpha interferon muteins, method for obtaining them and use
04/24/2008WO2007149730A3 Inhibitors of akt (protein kinase b)
04/24/2008WO2007121125A3 Hcv inhibitors
04/24/2008WO2007112703A3 Pharmaceutical composition containing the nmb0606 protein
04/24/2008WO2007012033A3 Il28 and il29 truncated cysteine mutants and antiviral methods of using same
04/24/2008US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug
04/24/2008US20080096954 Novel Bicyclic Compounds As Modulators of Androgen Receptor Function And Method
04/24/2008US20080096952 Methods for the treatment of atherosclerosis, using substituted phenethylsulfones
04/24/2008US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors
04/24/2008US20080096941 Halogenated benzamide derivatives
04/24/2008US20080096912 Indole, azaindole and related heterocyclic pyrrolidine derivatives
04/24/2008US20080096907 inhibitor of a mycobacteria thymidine monophosphate kinase (TMPK); mycobacteria is M. tuberculosis; leprosy; 5-Methyl-1-(4-bromo-benzyl)-1H-pyrimidine-2,4-dione from reaction of thymine with 4-bromo-benzylbromide; thymine or uracil derivatives
04/24/2008US20080096894 Anti-Bacterial Compounds
04/24/2008US20080096887 Benzene, Pyridine, and Pyridazine Derivatives
04/24/2008US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds
04/24/2008US20080096861 Chemical Compounds
04/24/2008US20080096850 Exposing Grampositive bacteria of vagina to a synergistic mixture including hexachlorophene, benzyl paraben, benzyl salicylate, a benzophenone, chlorophene, 2,4-diaminodiphenylamine, dichlorophene, HC Green No. 1, HC Orange No. 1, HC Red No. 1, isopropylbenzyl salicylate, and phenyl salicylate; tampons